Louis R. Lamontagne
Directeur Général chez Folia Biotech, Inc.
Profil
Louis R.
Lamontagne is the founder of PainCeptor Pharma Corp.
which was founded in 2003.
He was previously the President & Chief Executive Officer at Folia Biotech, Inc. since 2014 and also served as a Director at PainCeptor Pharma Corp.
Dr. Lamontagne has previously worked as the President & Chief Executive Officer at BELLUS Health, Inc., Research Director at The National Research Council, and Director at PARTEQ Innovations.
He holds a doctorate degree from McMaster University.
Postes actifs de Louis R. Lamontagne
| Sociétés | Poste | Début |
|---|---|---|
Folia Biotech, Inc.
 Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Directeur Général | 01/01/2014 |
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Louis R. Lamontagne
| Sociétés | Poste | Fin |
|---|---|---|
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Fondateur | 01/01/2009 |
PARTEQ Innovations
 PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Corporate Officer/Principal | - |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC. | Directeur Technique/Scientifique/R&D | - |
| BELLUS HEALTH | President | - |
Formation de Louis R. Lamontagne
| McMaster University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
The National Research Council
The National Research Council Miscellaneous Commercial ServicesCommercial Services The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC. | Commercial Services |
PARTEQ Innovations
PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Finance |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Retail Trade |
